The importance of the false-negative rate to validate a staging protocol for non-small cell lung cancer

Carme Obiols¹, Sergi Call^{1

2}, Ramon Rami-Porta^{1

3}

Affiliations

¹ Department of Thoracic Surgery, Hospital Universitari MútuaTerrassa, University of Barcelona, Terrassa, Spain.
² Department of Morphological Sciences, School of Medicine, Autonomous University of Barcelona, Bellaterra, Spain.
³ Network of Centers for Biomedical Research in Respiratory Diseases (CIBERES) Lung Cancer Group, Terrassa, Spain.

Editorial

Carme Obiols et al. Transl Lung Cancer Res. 2019 Dec.

. 2019 Dec;8(Suppl 4):S400-S402.

doi: 10.21037/tlcr.2019.07.04.

Carme Obiols¹, Sergi Call^{1

2}, Ramon Rami-Porta^{1

3}

¹ Department of Thoracic Surgery, Hospital Universitari MútuaTerrassa, University of Barcelona, Terrassa, Spain.
² Department of Morphological Sciences, School of Medicine, Autonomous University of Barcelona, Bellaterra, Spain.
³ Network of Centers for Biomedical Research in Respiratory Diseases (CIBERES) Lung Cancer Group, Terrassa, Spain.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Prediction Model for Nodal Disease Among Patients With Non-Small Cell Lung Cancer.
Verdial FC, Madtes DK, Hwang B, Mulligan MS, Odem-Davis K, Waworuntu R, Wood DE, Farjah F. Verdial FC, et al. Ann Thorac Surg. 2019 Jun;107(6):1600-1606. doi: 10.1016/j.athoracsur.2018.12.041. Epub 2019 Jan 30. Ann Thorac Surg. 2019. PMID: 30710518 Free PMC article.

1. Verdial FC, Madtes DK, Hwang B, et al. Prediction Model for Nodal Disease Among Patients With Non-Small Cell Lung Cancer. Ann Thorac Surg 2019;107:1600-6. 10.1016/j.athoracsur.2018.12.041 - DOI - PMC - PubMed
1. Silvestri GA, Gonzalez AV, Jantz MA, et al. Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:e211S-e250S. - PubMed
1. De Leyn P, Dooms C, Kuzdzal J, et al. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg 2014;45:787-98. 10.1093/ejcts/ezu028 - DOI - PubMed
1. Obiols C, Call S. Pros: should a patient with stage IA non-small cell lung cancer undergo invasive mediastinal staging? Transl Lung Cancer Res 2016;5:247-50. 10.21037/tlcr.2016.06.05 - DOI - PMC - PubMed
1. Lee PC, Port JL, Korst RJ, et al. Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. Ann Thorac Surg 2007;84:177-81. 10.1016/j.athoracsur.2007.03.081 - DOI - PubMed